Barclays

Shares of homebuilder D. R. Horton Inc (NYSE: DHI) are trading at just 1.9x an estimated first quarter 2019 tangible book value of $23.21 — which undervalues the stock, according to Barclays. The Analyst Barclays' Matthew Bouley upgraded D.R. Horton's stock from Equal Weight to...

Strong fundamentals in the overall cruise sector and a competitive position in the Caribbean leave Carnival Corp (NYSE: CCL) positioned for high upside potential, according to Barclays. The Analyst Analyst Felicia Hendrix upgraded Carnival from Equal Weight to Overweight and reiterated a $77...

Pre-open movers U.S. stock futures traded higher in early pre-market trade. The U.S Treasury budget report for February is schedule for release at 2:00 p.m. ET. Futures for the Dow Jones Industrial Average gained 96 points to 25,456.00, while the Standard & Poor’s 500 index futures rose 9...

Benzinga has featured looks at many investor favorite stocks over the past week. Bullish calls included top semiconductor stocks and the e-commerce leader. Bearish calls featured an electric vehicle giant and a video streaming leader. The bull run is now officially nine years old and there...

The market wasn’t impressed by Square Inc (NYSE: SQ)’s Q4 earnings report, sending the stock lower by more than 2.5 percent in the days following the report. Here’s a rundown of what Wall Street analysts had to say about the stock following its latest report. Voices From The...

What Happened Barclay’s recently hosted its 35th annual Barclays Industrial Select Conference, and analyst Brandon Oglenski summarized his takeaways from the airlines and transportation sectors in an investor note. According to Oglenski, investors have reason for optimism in 2018. Ogleski...

Despite General Electric Company (NYSE: GE)'s stock losing 15 percent of its value since the start of 2018 and more than 50 percent over the past year, Barclays isn't ready to recommend buying the stock. The Analyst Barclays' Julian Mitchell initiated coverage of General Electric...

Weatherford International Plc (NYSE: WFT)'s business is left severely impaired after two decades of mismanagement, poor execution and a culture unaccustomed to accountability, a Barclays analyst said.  The Analyst Barclays analyst David Anderson downgraded shares of Weatherford from...

Homebuilder Lennar Corporation (NYSE: LEN) announced a deal in October to buy CalAtlantic Group Inc (NYSE: CAA) for $7.7 billion, which would make the company one of the top three homebuilders in the U.S. The Analyst Barclays analyst Michael Dahl upgraded Lennar from Equal Weight to...

Credit Suisse Group AG (ADR) (NYSE: CS) took the trading community by surprise when the firm announced it will liquidate the popular Credit Suisse AG – VelocityShares Daily Inverse VIX Short Term ETN (NASDAQ: XIV) after the fund plunged more than 80 percent Monday, triggering an “...

Dr Pepper Snapple Group Inc. (NYSE: DPS) and privately owned Keurig Green Mountain Inc announced an $18.7-billion deal Jan. 29 to merge the two brands, with Dr Pepper Snapple shareholders receiving $103.75 per share in a special cash dividend and retaining 13 percent of the combined company. The...

Dicks Sporting Goods Inc (NYSE: DKS) may not be the Best Buy Co Inc (NYSE: BBY) of the sporting goods industry after all, according to a new Barclays report.  The Analyst   Matthew McClintock downgraded Dicks Sporting Goods from Equal Weight to Underweight and lowered the price...

Mallinckrodt PLC (NYSE: MNK) agreed to buy Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) in a deal announced in December. The Analyst Weighing in the planned acquisition, Barclays analyst Douglas Tsao downgraded shares of Mallinckrodt from Equal Weight to Underweight and lowered the price...

Pre-open movers U.S. stock futures traded lower in early pre-market trade, ahead of earnings reports from several companies. The Federal Open Market Committee will begin its two-day policy meeting today. The S&P Corelogic Case-Shiller home price index for November will be released at 9:00 a.m....

Allergan plc Ordinary Shares (NYSE: AGN) is down 26 percent over the last six months, but one analyst said there's only upside to its sickly state. The biotech’s trajectory inspired an upgrade from a three-year Hold. The Rating Barclays analyst Douglas Tsao upgraded Allergan to a Buy...